Real-time enrollment status for this chronic granulomatous disease (cgd) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:46 PM UTC
| NCT Number | NCT06325709 |
| Recruiting Status | Recruiting |
| Condition | Chronic Granulomatous Disease (CGD) |
| Phase | PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | August 13, 2026 (Aug 13, 2026) |
As of October 12, 2026: Clinical trial NCT06325709 is currently recruiting participants. This phase1 study for chronic granulomatous disease (cgd) is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06325709 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06325709 was last updated Aug 13, 2026 (August 13, 2026). HelloStudys verifies this status automatically.